{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03933995",
      "OrgStudyIdInfo": {
        "OrgStudyId": "PMC-P-09"
      },
      "Organization": {
        "OrgFullName": "Pharmicell Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction",
      "OfficialTitle": "Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 11, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 28, 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 30, 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 15, 2019",
      "StudyFirstSubmitQCDate": "April 28, 2019",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 1, 2019",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "October 20, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 22, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Pharmicell Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is a 5year (+-30 days) long term follow up study to evaluate the safety of autologous bone marrow derived mesenchymal stem cell in erectile dysfunction subject who participated in and completed the Phase 1 trials (refer to ClinicalTrials.gov.Identifier: NCT02344849).",
      "DetailedDescription": "This is a 5year (+-30 days) long term follow up study to evaluate the safety of autologous bone marrow derived mesenchymal stem cell in erectile dysfunction subject who participated in and completed the Phase 1 trials (refer to ClinicalTrials.gov.Identifier: NCT02344849).\n\nThis trial is planned to evaluate the safety of autologous bone marrow derived mesenchymal stem cell in patients with erectile dysfunction subject. Subjects who signed this follow-up observation informed consent form will participate in a safety assessment (tumor marker test, Serious Adverse Events, cancer incidence, recurrence of prostate cancer and vital sign)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Erectile Dysfunction"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Other"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cell",
            "ArmGroupDescription": "Long-term follow up of Mesenchymal stem cell group",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: no Intervention"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "no Intervention",
            "InterventionDescription": "no Intervention",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cell"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety Evaluation assessed by Tumor Marker Test.",
            "PrimaryOutcomeDescription": "Tumor Marker Test(reported in ng/mL): PSA, AFP, CEA Tumor Marker Test is optional item, not mandatory.\n\nIn this study, tumor markers divided into which are classified as \"Normal / Not clinical significant / Clinical significant\" abnormalities and analysis the frequency and proportion.",
            "PrimaryOutcomeTimeFrame": "5 year(+-30 days)"
          },
          {
            "PrimaryOutcomeMeasure": "Safety Evaluation assessed by Serious Adverse Events, cancer incidence and recurrence of prostate cancer.",
            "PrimaryOutcomeDescription": "Safety Evaluation assessed by Tumor Marker Test, patient reporting and vital signs\n\nFor each subject who has had one or more serious adverse events since the ongoing clinical trial, the severity of the adverse reaction should be provided for each causal relationship, and the incidence of serious adverse events should be analyzed.",
            "PrimaryOutcomeTimeFrame": "5 year(+-30 days)"
          },
          {
            "PrimaryOutcomeMeasure": "Safety Evaluation assessed by Vital Signs.",
            "PrimaryOutcomeDescription": "Vital Sign : Blood pressure(reported in mmHg), Pulse(reported in time/min) Vital Sign is optional item, not mandatory.\n\nThe vital sign values obtained from this study were compared for each group. Baseline statistics (mean, standard deviation, median, maximum, and minimum) are presented, and clinically significant figures are summarized and presented based on the normal range for each value.",
            "PrimaryOutcomeTimeFrame": "5 year(+-30 days)"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects who treated with Mesenchymal stem cell and enrolled the phase 1 study(NCT02344849).\nSubjects who can agree to participate in the long term observation study by oneself.\n\nExclusion Criteria:\n\nNot Applicable",
      "HealthyVolunteers": "No",
      "Gender": "Male",
      "MinimumAge": "20 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Subjects who treated with Mesenchymal stem cell and enrolled the phase 1 study(NCT02344849).",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "JIYEOUN JEONG, bachelor",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "82-02-3496-0134",
            "CentralContactEMail": "jyjeong@pharmicell.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Chungsu Kim, Ph.D",
            "OverallOfficialAffiliation": "Asan Medical Center",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Asan medical center",
            "LocationStatus": "Recruiting",
            "LocationCity": "Seoul",
            "LocationCountry": "Korea, Republic of",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chungsu Kim, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "cskim@amc.seoul.kr"
                },
                {
                  "LocationContactName": "Chungsu Kim",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007172",
            "ConditionMeshTerm": "Erectile Dysfunction"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012735",
            "ConditionAncestorTerm": "Sexual Dysfunction, Physiological"
          },
          {
            "ConditionAncestorId": "D000020018",
            "ConditionAncestorTerm": "Sexual Dysfunctions, Psychological"
          },
          {
            "ConditionAncestorId": "D000001523",
            "ConditionAncestorTerm": "Mental Disorders"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9369",
            "ConditionBrowseLeafName": "Erectile Dysfunction",
            "ConditionBrowseLeafAsFound": "Erectile Dysfunction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14698",
            "ConditionBrowseLeafName": "Sexual Dysfunction, Physiological",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21026",
            "ConditionBrowseLeafName": "Sexual Dysfunctions, Psychological",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3967",
            "ConditionBrowseLeafName": "Mental Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13625",
            "ConditionBrowseLeafName": "Psychotic Disorders",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXM",
            "ConditionBrowseBranchName": "Behaviors and Mental Disorders"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}